No spin needed really. I just read it. It’s a perfectly adequate paper from the Tbilisi group in a reasonable journal. The authors’ conclusions are fair and balanced in concluding efficacy data is inconclusive (their words) and drug seems safe and well tolerated. It’s a bit outdated maybe , seems to have taken a while to make it to print, but they got there in the end.
Ann: Publications Positive Review of Veyonda in Chemotherapy, page-8
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
